<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01762683</url>
  </required_header>
  <id_info>
    <org_study_id>LIRUSSI-AOI-2011</org_study_id>
    <nct_id>NCT01762683</nct_id>
  </id_info>
  <brief_title>Influence of Preconceptional Obesity on the Myometrial Cells Differentiation Toward a Contractyl Phenotype</brief_title>
  <acronym>ObeDi</acronym>
  <official_title>Study of Role of Mononuclear Cells of Maternal Peripheric Blood in Human Myometrial Primar Cell Lines Differentiation Toward a Contratyl Phenotype: Influence of Preconceptional Obesity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Dijon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Dijon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to improve the understanding of cellular mecanism involved in
      delivery disorders in obese women, first by characterizing the hyperplasia phenomenon of
      myometrail cells induced by inflammatory stimulation (Il-1B), then by studying the role of
      blood mononuclear cells, of leptine and of obese women sera to interfere with the transition
      of myometrial cells toward hyperplasia phenotype.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 6, 2012</start_date>
  <completion_date type="Actual">January 15, 2016</completion_date>
  <primary_completion_date type="Actual">January 15, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Measuring the expression level of markers (Gama actine, Desmine, Connexine-43, and Ocytocine receptor) by Westernblotting</measure>
    <time_frame>up to 2 months</time_frame>
    <description>Demonstrate in vitro the capacity of a Il-1B stimulus to induce the differentiation of the myometrial cells toward a hyperplasia phenotype, and that the answer depends on whether this is cells from normal weight women or obese women before conception.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">38</enrollment>
  <condition>Pregnancy Complication</condition>
  <arm_group>
    <arm_group_label>pre-conceptional obesity with a scheduled cesarean section</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>non-obese women with a scheduled cesarean section</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>women entering labour</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>women entering labour for vaginal delivery and for vaginal delivery</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Myometrium biopsy and blood samples</intervention_name>
    <description>The biopsy of myometrium is specially realised for the study in surgical unit after the release of the child, in women with normal pregnancy but necessitating a caesarean.
The blood samples are realised, specially for the study, either during the medical exam before the ceasarean or specifically for the study.</description>
    <arm_group_label>non-obese women with a scheduled cesarean section</arm_group_label>
    <arm_group_label>pre-conceptional obesity with a scheduled cesarean section</arm_group_label>
    <arm_group_label>women entering labour</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Informed consent signed

          -  Patient affiliated with a social security scheme

          -  In front of for obstetrical reasons to give birth by caesarean section (scheduled
             caesarean section)

          -  Or a woman who is not obese in labour and needs to undergo a cesarean section

          -  No obvious infectious context

          -  Age &gt; 18 years old

        Exclusion Criteria:

          -  Obvious inflammatory or autoimmune diseases

          -  Suspected or confirmed infectious context, including virale infection VIH, VHC, VHB

          -  Coagulation disorders
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Maternit√© du CHU de Dijon</name>
      <address>
        <city>Dijon</city>
        <state>Bourgogne</state>
        <zip>21000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Sainte Marthe</name>
      <address>
        <city>Dijon</city>
        <zip>21000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <study_first_submitted>May 31, 2012</study_first_submitted>
  <study_first_submitted_qc>January 7, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 8, 2013</study_first_posted>
  <last_update_submitted>December 20, 2018</last_update_submitted>
  <last_update_submitted_qc>December 20, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">December 21, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>pregnancy</keyword>
  <keyword>obesity</keyword>
  <keyword>differentiation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pregnancy Complications</mesh_term>
    <mesh_term>Obesity</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

